NEW YORK, Oct. 22, 2018 /PRNewswire/ -- Chardan, a global investment bank, announced today that the firm acted as lead managerin the initial public offering of LogicBio Therapeutics, Inc. (NASDAQ: LOGC), raising aggregate gross proceeds of approximately $70.0 million. LogicBio began trading on the NASDAQ Capital Market on October
Chardan has participated in advisory and capital raising transactions totaling more than $2 billion in 2018.
Chardan is an independent global investment bank specializing in healthcare, SPACs and emerging growth companies. Our range of services include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading. Headquartered in New York City, Chardan is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: FINRA, SIPC, NASDAQ and the NYSE Arca, Inc.
Learn more about Chardan: www.chardan.com
Media Contact: Emily Levine, Chardan email@example.com (646) 465-9018
Tom Rozycki, Prosek Partnerstrozycki@prosek.com (646) 503-5657
View original content:http://www.prnewswire.com/news-releases/chardan-serves-as-lead-manager-for-logicbio-therapeutics-300735489.html
SOURCE Chardan Capital Markets, LLC
Subscribe to our Free Newsletters!
Body wraps is an all natural remedy to slenderizing & contouring your body that not just hydrate ...
Eat more potassium rich foods and lower your risk for high blood pressure and kidney stones. ...
Wet dreams or nightfall is the involuntary ejaculation occurring during sleep. It is fairly common ...View All